Targeting chemokines for acute lymphoblastic leukemia therapy

Overview of attention for article published in Journal of Hematology & Oncology, March 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 17,245 followers.

RT @smbenlazar: Targeting chemokines for acute lymphoblastic leukemia therapy | Journal of Hematology & Oncology | #ALL #leusm https://t.co…

RT @smbenlazar: Targeting chemokines for acute lymphoblastic leukemia therapy | Journal of Hematology & Oncology | #ALL #leusm https://t.co…

RT @smbenlazar: Targeting chemokines for acute lymphoblastic leukemia therapy | Journal of Hematology & Oncology | #ALL #leusm https://t.co…

Targeting chemokines for acute lymphoblastic leukemia therapy | Journal of Hematology & Oncology | #ALL #leusm https://t.co/92lLpEuvvh https://t.co/Z3NZtCq2wT

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.